Industry Leaders Gather as Wanguiyuan and Northwest University Unveil Joint Microfluidics Institute

On December 15, 2023, the unveiling ceremony and signing event for Wanguiyuan and the Institute of Biomedical Microfluidics at Northwest University concluded successfully. The event brought together representatives from the Wujiang Economic Development Zone government departments, leading biomedical research institutes, upstream service providers, midstream clients, downstream hospital laboratory departments, as well as relevant social capital investors and media, to jointly witness this significant moment.

Distinguished guests in attendance included Zhu Yungen, Member of the Party Working Committee and Deputy Director of the Administrative Committee of Wujiang Economic and Technological Development Zone; Yang Tao, Director of the Science and Technology Department at Northwest University; Mi Xianqiang, Level-II Researcher and Doctoral Supervisor at the Shanghai Institute of Microsystem and Information Technology, Chinese Academy of Sciences; Shen Hao, Director of the Science and Technology Department at Suzhou Ninth People’s Hospital; Jin Yichao, General Manager of the Business Division at Hangzhou Hunter Biotechnology Co., Ltd.; Dr. Hu Jie, CTO of Suzhou DiYinAn Biotechnology Co., Ltd.; Cai Wanxu, Vice President of Suzhou Guofa Chuangxin Capital Investment Co., Ltd.; and Lin Xiaofan, President of Shenzhen Qianhai Sihai New Material Investment Fund Management Co., with nearly 100 guests present in person.

The event mainly consists of four agenda items: leadership address, unveiling ceremony, customer signing, and venture capital signing.

Zhu Yungen, Deputy Director of the Administrative Committee of Wujiang Economic and Technological Development Zone, Delivered an Address

Wujiang Economic and Technological Development Zone, located within the Yangtze River Delta Eco-Green Integrated Development Demonstration Zone, is situated at the intersection of the “Taihu Lake Science and Technology Innovation Circle” and the “Wusong River Science and Technology Innovation Belt,” boasting significant transportation and locational advantages.

In recent years, the Wujiang Economic and Technological Development Zone has consistently regarded talent as the “primary resource” underpinning development. It has implemented the “Chongben” Talent Project and a “Talent + Fund + Project” attraction mechanism, while vigorously advancing the dual initiatives of attracting investment and recruiting talent. Meanwhile, venture capital funds have actively participated in investments, empowering corporate growth and fostering public listings, thereby establishing a robust development pathway that spans from assisting startups in settling locally, nurturing their growth, supporting their expansion, to facilitating their initial public offerings.

Wujiang Economic and Technological Development Zone will continue to support Suzhou Wanguiyuan Precision Technology Co., Ltd. by providing high-quality services and comprehensive safeguards, acting as a “gold-standard concierge” for businesses. The Zone is committed to leveraging policies to benefit enterprises, optimizing the business environment to invigorate companies, and enhancing services to assist their growth, thereby unleashing Wanguiyuan’s stronger innovation potential. This collaboration aims to empower the high-quality development of Wujiang Economic and Technological Development Zone and achieve a win-win vision for both the local region and the enterprise.

Yang Tao, Director of the Science and Technology Department of Northwest University, Delivered an Address

Northwest University is a comprehensive university with 121 years of history and cultural heritage. From being a national key university, to a university under the “Project 211” initiative, and now to a university under the “Double First-Class” initiative, Northwest University has always held a pivotal position and played an irreplaceable role in China’s higher education landscape. The university has consistently regarded serving national and local economic and social development as its mission, adhering to the principle of “strengthening foundational knowledge, enhancing practical applications, emphasizing interdisciplinary integration, and promoting transformation.” It places emphasis on interdisciplinary studies, encourages industry-university-research collaboration, innovates operational mechanisms, integrates scientific and technological advancements with industrial development, and has achieved remarkable results.

Wanguiyuan’s platform and technical resources possess distinct advantages that complement the university’s scientific and educational assets. Engaging in research collaboration with the company holds significant importance for advancing the university’s scientific research, fostering academic achievements, and cultivating talent. The joint establishment of the Microfluidics Biomedical Industry Research Institute marks a significant milestone in industry-university-research collaboration. It also provides new opportunities for the university to leverage the rapid development of the Yangtze River Delta region, align with the “Four Orientations,” and serve the economic and social development of Suzhou, particularly Wujiang District, through technological innovation. We believe that, with strong support from Wujiang District and the concerted efforts of both the university and the enterprise, the Microfluidics Research Institute will become a vital platform for the university to promote interdisciplinary development and for the company to drive industrial advancement.

Mr. Zhang Cangmin, Founder of Wanguiyuan, Delivered a Speech

The joint establishment of the “Institute for Microfluidics Technology in Biopharmaceutical Industry” by Wanguiyuan and Northwest University represents a significant breakthrough for both parties and the industry, marking a perfect integration of academic research and industrial commercialization.

Wanguiyuan operates in the life sciences sector, a field characterized by long-term growth potential and substantial barriers to entry. Since its inception, the company has remained committed to taking the difficult yet correct path. Throughout this journey, it has garnered support and recognition from the scientific research community, industry partners, investors, and leaders at various levels of the development zone. Our relentless pursuit is to continuously enhance our closed-loop service capability system, building an integrated CDMO service platform that combines automation, chip-based consumables, and life science instruments. The original intention behind establishing the research institute was to serve as an effective bridge, facilitating the successful translation of laboratory research outcomes into practical applications, while ensuring that downstream users benefit from high-quality, cost-effective microfluidic products. As winter arrives, spring is sure to follow. Wanguiyuan will continue to press forward unwaveringly in the life sciences arena, translating commitment into far-reaching impact. With a promising future ahead, we are determined to make the most of our time and deliver on our potential.

In the coming year and the years ahead, Wanguiyuan will proactively strengthen communication and collaboration with universities, research institutes, scientific research organizations, and relevant government departments. By introducing cutting-edge industry technologies and top-tier talent, we will expand and deepen the application of microfluidics technology in the biopharmaceutical sector. Leveraging the strategic advantages of our integrated platform for industry, academia, research, and application, we aim to further breakthrough core application technologies, promote the integration of industry-academia-research efforts and the transformation of scientific achievements, and establish our research institute as a central hub connecting industry applications. Our mission is to empower the industry and create value for our customers.

Unveiling Ceremony of the Microfluidics Biomedical Research Institute of “Northwest University” and “Wanguiyuan”

“DiYinAn” and “Wanguiyuan” CDMO Strategic Cooperation Signing Ceremony for In Vitro Diagnostic Automation Equipment, Instrument Modules, and Biological Consumables

“Hunter Biotechnology” and “Wanguiyuan Zebrafish Series Equipment CDMO Strategic Cooperation Signing Ceremony

“Suzhou Venture Capital” and “Shenzhen Sihai New Materials” Investment in Wanguiyuan Signing Ceremony

Suzhou Wanguiyuan Precision Technology Co., Ltd., established in 2018, is recognized as a “National High-Tech Enterprise,” a “Wujiang District Leading Talent Enterprise,” and a “Suzhou Entrepreneurial Leading Talent Enterprise.” The company specializes in the R&D and manufacturing of high-end biological consumables and instruments, represented by microfluidic chips, as well as process development, mold manufacturing, and mass production services. Committed to providing high-quality services for molecular diagnostics, cell culture, immunotherapy, biopharmaceuticals, and medical devices, its service areas cover IVD (in vitro diagnostics), medical devices, and biomedicine. It serves as your trusted partner for diverse biomedical engineering solutions.

The company continues to deepen its expertise in the life sciences sector, establishing a comprehensive intelligent automation technology platform that covers all scenarios and the entire value chain. After years of R&D accumulation, it now possesses end-to-end capabilities spanning research and development, manufacturing, and production to meet customer needs.